PSA
55
-3
SRE
63
-3
URI
66
-3
C
58
-4
AVY
51
-2
PLD
51
-5
KHC
15
-2
IR
68
-3
AAL
59
2
VRTX
53
-5
VMC
59
-4
EQR
53
-7
UNP
42
-4
MTCH
30
8
ADT
55
-3
CVX
47
9
HUM
46
-2
ZTS
47
-2
DVN
21
-8
AES
44
3
PSA
55
-3
SRE
63
-3
URI
66
-3
C
58
-4
AVY
51
-2
PLD
51
-5
KHC
15
-2
IR
68
-3
AAL
59
2
VRTX
53
-5
VMC
59
-4
EQR
53
-7
UNP
42
-4
MTCH
30
8
ADT
55
-3
CVX
47
9
HUM
46
-2
ZTS
47
-2
DVN
21
-8
AES
44
3
Financhill
Back

Protagonist Therapeutics Vs. Leidos Holdings Industry Stock Comparison

Sell
29

PTGX
Protagonist Therapeutics

Last Price:
41.02
Seasonality Move:
12.96%
Sell
40

LDOS
Leidos Holdings

Last Price:
167.94
Seasonality Move:
2.48%
Sell
29
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.04. The Score for PTGX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Leidos Holdings (LDOS) is a Sell

Is Leidos Holdings a Buy, Sell or Hold?

  • The current Leidos Holdings [LDOS] share price is $167.96. The Score for LDOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LDOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

LDOS Stock Price Chart

What is Leidos Holdings's stock price today?

  • The Leidos Holdings share price today is $167.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LDOS is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 31.27 Sell
Chaikin Money Flow: -545696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.4 - 47.92) Sell
Bollinger Bands (100): (37.27 - 46.33) Sell

LDOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.47 Buy
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: -4188569 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (166.87 - 191.75) Sell
Bollinger Bands (100): (144.85 - 173.49) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.09 Sell
20-day SMA: 46.22 Sell
50-day SMA: 45.54 Sell
200-day SMA: 35.33 Buy
8-day EMA: 44.31 Sell
20-day EMA: 45.44 Sell
50-day EMA: 44.68 Sell
200-day EMA: 36.59 Buy

LDOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.54 Sell
20-day SMA: 182.33 Sell
50-day SMA: 169.14 Sell
200-day SMA: 146.05 Buy
8-day EMA: 188.31 Sell
20-day EMA: 183.52 Sell
50-day EMA: 172.61 Sell
200-day EMA: 148.04 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Leidos Holdings Earnings Growth & LDOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.05 per share, and an increase next year of $0.31 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Leidos Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):